Publications

Journal Article
Review
Epublish 4 citations
Electronic publication date
October 26, 2024

View on Pubmed.gov 39456701 | View on doi.org 10.3390/ijms252...

Unveiling the Role of Gut Microbiota and Metabolites in Autoimmune Thyroid Diseases: Emerging Perspectives.

Search for publications in this journal Int J Mol Sci

  • Kai Yan

    Search for this expert
    1
  • Xin Sun

    Search for this expert
    2
  • Chenxi Fan

    Search for this expert
    1
  • Xin Wang 2
  • Hongsong Yu

    Search for this expert
    1

Abstract

Autoimmune thyroid diseases (AITDs) are among the most prevalent organ-specific autoimmune disorders, with thyroid hormones playing a pivotal role in the gastrointestinal system's structure and function. Emerging evidence suggests a link between AITDs and the gut microbiome, which is a diverse community of organisms that are essential for digestion, absorption, intestinal homeostasis, and immune defense. Recent studies using 16S rRNA and metagenomic sequencing of fecal samples from AITD patients have revealed a significant correlation between a gut microbiota imbalance and the severity of AITDs. Progress in animal models of autoimmune diseases has shown that intervention in the gut microbiota can significantly alter the disease severity. The gut microbiota influences T cell subgroup differentiation and modulates the pathological immune response to AITDs through mechanisms involving short-chain fatty acids (SCFAs), lipopolysaccharides (LPSs), and mucosal immunity. Conversely, thyroid hormones also influence gut function and microbiota composition. Thus, there is a bidirectional relationship between the thyroid and the gut ecosystem. This review explores the pathogenic mechanisms of the gut microbiota and its metabolites in AITDs, characterizes the gut microbiota in Graves' disease (GD) and Hashimoto's thyroiditis (HT), and examines the interactions between the gut microbiota, thyroid hormones, T cell differentiation, and trace elements. The review aims to enhance understanding of the gut microbiota-thyroid axis and proposes novel approaches to mitigate AITD severity through gut microbiota modulation.

References

ISME J. 2021 Nov;15(11):3399-3411

Int J Mol Sci. 2023 Jul 28;24(15):

Int J Mol Sci. 2023 Feb 26;24(5):

Int J Mol Sci. 2021 Feb 17;22(4):

Cited by 4 citations (total)

Journal Article Review

Exploring How Adipose Tissue, Obesity, and Gender Influence the Immune Response to Vaccines: A Comprehensive Narrative Review.

Electronic publication date January 25, 2025

Search for publications in this journal Int J Mol Sci

Juan Bautista De Sanctis [...] Alexis Hipólito García et al.

Vaccines represent an essential tool for the prevention of infectious diseases. Upon administration, a complex interaction occurs between the vaccine...

Journal Article

Correlations between serum cytokines and gut microbiota in patients with Graves' disease: A case-control study.

Electronic publication date June 24, 2025

Search for publications in this journal Medicine (Baltimore)

Hong Chao [...] Xue Yan Qian et al.

Graves' disease (GD) is the most prevalent autoimmune thyroid disorder. Gut microbiome as a critical modulator of autoimmune pathogenesis through...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances